CECELIA CURTIS: Open Payments
NPI 1073116992 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 52 payments from 13 companies in 2025. Trend: 2023 $1,544 · 2024 $727 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $359 |
| PFIZER INC. | 10 | $212 |
| Eisai Inc. | 2 | $145 |
| Novo Nordisk Inc | 5 | $94 |
| Astellas Pharma US Inc | 4 | $75 |
| Exact Sciences Corporation | 4 | $75 |
| Abbott Laboratories | 2 | $39 |
| Actelion Pharmaceuticals US, Inc. | 1 | $34 |
| Lundbeck LLC | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
Products named: VRAYLAR, NURTEC ODT, Leqembi, Veozah, Cologuard Collection Kit, Wegovy, ELIQUIS, UBRELVY.
Industry payments across VA — which companies pay providers there.
